Memantine for the treatment of frontotemporal dementia: a meta-analysis
Taro Kishi, Shinji Matsunaga, Nakao Iwata Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan Background: There is no conclusive evidence supporting the efficacy of memantine in frontotemporal dementia (FTD). We conducted a comprehensive meta-analysis of memantine...
Guardado en:
Autores principales: | Kishi T, Matsunaga S, Iwata N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dd83ed873e184510ba2f258a527f8d02 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia
por: Chow TW, et al.
Publicado: (2011) -
The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis
por: Kishi T, et al.
Publicado: (2017) -
Memantine treatment for Japanese patients with moderate to severe Alzheimer’s disease: a meta-analysis of double-blind, randomized, placebo-controlled trials
por: Kishi T, et al.
Publicado: (2018) -
Frontotemporal dementia and primary progressive aphasia, a review
por: Kirshner HS
Publicado: (2014) -
Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramine
por: Kishi T, et al.
Publicado: (2014)